Literature DB >> 3003193

Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.

J C Lee, L Rebar, P Young, F W Ruscetti, N Hanna, G Poste.   

Abstract

Culture supernatants of several human T cell leukemia cell lines were screened for macrophage-activating activity (MAF) as defined by induction of tumoricidal activity against human melanoma cells in a 72-hr assay. Two cell lines, MT-2 and C10/MJ2, were found to produce high levels of MAF activity constitutively, but the MT-2 cell line, unlike C10/MJ2, produced little IFN-gamma. This observation was confirmed by Northern blot analysis performed with specific IFN-gamma cDNA probe. The MT-2 cell line thus provides a useful system to evaluate the existence of lymphokines with MAF activity that are distinct from IFN-gamma. The MAF activity produced by MT-2 cells was distinguished from IFN-gamma by the following criteria. MAF activity was not removed by immunoaffinity chromatography with the use of immobilized specific polyclonal antibodies to IFN-gamma and was not neutralized by a monoclonal antibody to IFN-gamma. Heat or acid treatments of IFN-gamma resulted in loss of its antiviral activity, but these treatments had no effect on MAF activity. MAF activity was not abolished by polymyxin B sulfate, suggesting that this activity is not mediated by or dependent on LPS. Initial characterization studies performed by using membrane filtration, gel filtration chromatography, and isoelectric focusing indicate that the non-IFN-gamma MAF activity produced by MT-2 cells has an apparent m.w. of 55,000 and an isoelectric point of 5.5. Collectively, these data suggest that the MT-2 human T cell line constitutively produces high levels of MAF and low levels of IFN-gamma and offers a useful source for the further purification of a unique human lymphokine with macrophage-activating activity that is distinct from IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003193

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon.

Authors:  B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

2.  Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity.

Authors:  K Kagaya; K Watanabe; Y Fukazawa
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Human monocyte-derived macrophages are lysed by schistosomula of Schistosoma mansoni and fail to kill the parasite after activation with interferon gamma.

Authors:  H G Remold; A Mednis; A Hein; J P Caulfield
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

4.  Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni.

Authors:  I Esparza; D Männel; A Ruppel; W Falk; P H Krammer
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

5.  Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.

Authors:  W Y Weiser; A Van Niel; S C Clark; J R David; H G Remold
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.